Ironwood Pharmaceuticals | IRWD - Gross Profit On Sales



Ironwood Pharmaceuticals reported $3.65M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.


Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 243.83M 19.91M Jun/2025
Agios Pharmaceuticals USD 10.75M 3.11M Jun/2025
Almirall EUR 191.9M 185.49M Mar/2025
Alnylam Pharmaceuticals USD 630.74M 107.59M Jun/2025
Amarin USD 25.13M 1.78M Mar/2025
Ardelyx USD 82.84M 15.02M Jun/2025
Astellas Pharma JPY 410.96B 28.53B Jun/2025
AstraZeneca USD 11.98B 637M Jun/2025
Charles River Laboratories USD 291.68M 48.42M Jun/2025
Exact Sciences USD 562.45M 61.91M Jun/2025
Halozyme Therapeutics USD 279.36M 62.9M Jun/2025
Incyte USD 1.14B 151.67M Jun/2025
Ironwood Pharmaceuticals USD 3.65M 60.36M Sep/2024
MacroGenics USD -27460000 41.32M Jun/2025
Moderna USD 18M 1000K Jun/2025
Myriad Genetics USD 134.2M 16.7M Mar/2025
Pacira USD 125.91M 8.71M Jun/2025
PTC Therapeutics USD 163.39M 999.84M Jun/2025
Sarepta Therapeutics USD 457.87M 149.43M Jun/2025
Takeda JPY 722.01B 50.69B Jun/2025
Ultragenyx Pharmaceutical USD 143.49M 32.86M Jun/2025